Clinical Trial Update: MAD Trial: Myopia Atropine Dose [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating different doses of atropine eye drops to slow progression of progressive myopia in children. Recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Progressive Myopia

Drugs mentioned

• Atropine (atropine)

Snippet

Sponsor: Erasmus Medical Center | Conditions: Progressive Myopia | Phase 3 | Status: RECRUITING